Trial Profile

Pharmacokinetics of Invanz (Ertapenem) in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Apr 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ertapenem (Primary)
Indications Bacterial infections
Focus Pharmacokinetics

Most Recent Events

09 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
05 May 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
09 Apr 2009 New trial record

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com